Data monitoring in complex clinical trials: Which treatment is ''better''? (Q1338366): Difference between revisions
From MaRDI portal
Set profile property. |
ReferenceBot (talk | contribs) Changed an Item |
||
(One intermediate revision by one other user not shown) | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.1016/0378-3758(94)90199-6 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2003324233 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Predictive Probability Early Termination Plans For Phase II Clinical Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Discrete Sequential Boundaries for Clinical Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Stochastically curtailed tests in long–term clinical trials / rank | |||
Normal rank |
Latest revision as of 10:37, 23 May 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Data monitoring in complex clinical trials: Which treatment is ''better''? |
scientific article |
Statements
Data monitoring in complex clinical trials: Which treatment is ''better''? (English)
0 references
28 November 1995
0 references